+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PPLPHARMA

Piramal Pharma Share Price

 
33.94% Gain from 52W Low

 

Piramal Pharma live price: ₹177.20. It opened at ₹184 vs previous close ₹185; intraday high/low: ₹184/₹176. The 50 & 200 DMA stand at ₹169.70/₹172.30.

Piramal Pharma Performance

  • Today's Low
  • ₹176
  • Today's High
  • ₹184
  • 52 Week Low
  • ₹132
  • 52 Week High
  • ₹212
  • Open Price₹184
  • Previous Close₹185
  • Volume7,764,069
  • 50 DMA₹169.70
  • 100 DMA₹167.80
  • 200 DMA₹172.30

Piramal Pharma Chart

Investment Returns

  • Over 1 Month + 11.52%
  • Over 3 Month + 17.5%
  • Over 6 Month + 14.24%
  • Over 1 Year -16.3%

Smart Investing Starts Here Start SIP with Piramal Pharma for Steady Growth!

Invest Now

Piramal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -72.4
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 23,592
  • P/B Ratio
  • 2.9
  • Average True Range
  • 7
  • EPS
  • -2.4
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.2
  • RSI
  • 64.89
  • MFI
  • 76.88

Latest Stock News Updates

Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Please find enclosed intimation of Analyst Meet scheduled to be held on 30th July 2026.

Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter Ended 30Th June, 2026.

Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter ended 30th June, 2026.

Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund

Piramal Pharma Financials

Piramal Pharma Technicals

EMA & SMA

Current Price
₹177.20
-7.61 (-4.12%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹173.80
  • 50 Day
  • ₹169.70
  • 100 Day
  • ₹167.80
  • 200 Day
  • ₹172.30

Resistance and Support

179.03 Pivot Speed
  • R3 200.30
  • R2 193.00
  • R1 188.90
  • S1 177.60
  • S2 170.30
  • S3 166.20

Piramal Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-29 Quarterly Results
2026-04-28 Audited Results
2026-01-28 Quarterly Results
2025-11-05 Quarterly Results
2025-07-28 Quarterly Results
Date Purpose Remarks
2025-07-16 FINAL Rs.0.14 per share(1.4%)Final Dividend
2024-07-12 FINAL Rs.0.11 per share(1.1%)Final Dividend
View Piramal Pharma Dividend History Arrow

Piramal Pharma Shareholding Pattern

37.62%
34.8%
13.18%
12.51%
1.39%

About Piramal Pharma

Piramal Pharma is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. We operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (“CDMO”) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (“APIs”), Finished dosage forms (“FDFs”), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (“CHG“) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and Piramal Consumer Healthcare (“PCH“) business, selling well-known OTC brands. View More
  • NSE Symbol
  • PPLPHARMA
  • BSE Symbol
  • 543635
  • ISIN
  • INE0DK501011

Similar Stocks to Piramal Pharma

Piramal Pharma FAQs

Piramal Pharma share price is ₹177 As on 22 July, 2026 | 14:23

The Market Cap of Piramal Pharma is ₹23591.5 Cr As on 22 July, 2026 | 14:23

The P/E ratio of Piramal Pharma is -72.4 As on 22 July, 2026 | 14:23

The PB ratio of Piramal Pharma is 2.9 As on 22 July, 2026 | 14:23

The 52 week High & Low of Piramal Pharma is ₹212.4/₹132.3 respectively As on 22 July, 2026 | 14:23

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23